Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$43.29
-1.06%
Mkt Cap $2.40B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (10 analysts)
$65.00
Range $65.00 – $65.00
Implied Upside
+50.2%
Consensus $65.00 vs current $43.29